Enhertu shows promise in Phase 3 HER2-positive breast cancer trial
The study showed a significant improvement in pathologic complete response (pCR) rates when Enhertu was followed by paclitaxel, trastuzumab, and pertuzumab (THP), compared to the standard of care in the...
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry